2m 2m 2m 2m 2m 2m 2m
GENERATE BIO (GENB)
NASDAQ
$12.81-$0.30 (-2.29%)
Price as of Oct 22, 2026 7:35 PM EDT- $1.7BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
GENERATE BIO (GENB)
$12.81-$0.30 (-2.29%)
GENB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.11 | ||
Change | +$0.21 (+1.63%) | ||
Open | $13.04 | ||
High | $13.21 | ||
Low | $12.80 | ||
Previous Close | $12.90 | ||
Volume | 421,199 | ||
30-Day Average Volume | 1,064,884 | ||
1-Week Change | 4.71% | ||
1-Month Change | -24.57% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 128.4M | ||
Total Assets | $561.7M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $6.3M | ||
Net Income | -$67.3M | ||
Free Cash Flow | -$58.9M | ||
EBIT | -$67.2M | ||
EBITDA | -$64.0M | ||
Net Working Capital | $413.6M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 245 | ||
P/B | 4 | ||
P/E | -25 | ||
PEG | -0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||